MetaCap

OptimizeRx (OPRX) vs Zhihu (ZH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Zhihu (ZH) has outperformed OptimizeRx (OPRX) over the past year, losing 49.1% versus a loss of 54.1%. Over five years, OPRX leads with a -90.2% price change compared with -95.7% for ZH. Zhihu is the larger company by market cap ($169.3 million vs $126.7 million), about 1.3 times the size, while OptimizeRx is growing revenue faster (+18.8% vs -20.3%).

On valuation, OptimizeRx trades at a lower forward P/E (6.4x vs 36.6x for Zhihu). OptimizeRx converts more of its revenue into profit, with a net margin of 4.7% versus -7.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OPRX-54.08%ZH-49.12%
+9%-32%-73%
Nov 21, 20251 yearNov 20, 2026
OPRX-90.66%ZH-95.72%
+5%-48%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OPRX versus ZH key metrics
MetricOPRXZH
Share price$6.70$2.03
Market cap$126.68M$169.26M
1-day change-4.42%-16.12%
YTD return-45.35%-38.11%
1-year return-54.08%-49.12%
5-year return-90.22%-95.69%
P/E ratio (TTM)25.77—
Forward P/E6.3736.65
EPS (TTM)$0.26$-0.54
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$109.43M$393.10M
Revenue growth (YoY)+18.78%-20.27%
Net income (latest FY)$5.13M$-27.91M
Gross margin67.25%59.94%
Operating margin10.69%-18.45%
Net margin4.69%-7.10%
52-week high$15.59$4.52
52-week low$4.54$1.99
Distance from 52-week high-57.02%-55.09%
Analyst consensusstrong_buynone
Avg. price target upside+77.61%+101.48%
Average volume190.65K405.99K
Shares outstanding18.91M78.42M
Employees1321,149
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • OptimizeRx is more profitable, keeping 4.7 cents of every revenue dollar as net income versus -7.1 cents for Zhihu.
  • OptimizeRx grew revenue faster in its latest fiscal year (+18.78% vs -20.27%).

About OptimizeRx

OPRX stock →

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.

Consumer Discretionary · Business Services · 132 employees

About Zhihu

ZH stock →

Zhihu Inc., together with its subsidiaries, operates an online content community in the People's Republic of China. The company offers contents in various categories, including career development, science and technology, business and finance, consumer decision-making, lifestyle, entertainment, and others.

Consumer Discretionary · Business Services · 1,149 employees

OPRX vs ZH FAQ

Which is bigger, OptimizeRx or Zhihu?

Zhihu (ZH) is larger, with a market capitalization of $169.26M compared with $126.68M for OptimizeRx (OPRX).

Which stock has performed better over the past year, OPRX or ZH?

ZH returned -49.12% over the past 12 months, compared with -54.08% for OPRX (price return, excluding dividends). Past performance does not predict future results.

Are OptimizeRx and Zhihu in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons